# In 2015, GE Healthcare signed a memorandum of understanding with the Oregon Health & Science University (U.S.) to undertake collaborative R&D studies in the field of cardiovascular imaging & treatment as well as in big data research.
# In 2015, GE Healthcare launched a new 4D cardiac ultrasound software—cSound—for three new ultrasound systems, namely, VividS70, VividE90, and VividE95 in the U.S. and some countries in Europe, Asia, and LatinAmerica.
The cardiovascular ultrasound system market is projected to reach USD 1.66 Billion by 2021 from USD 1.27 Billion in 2016, growing at a CAGR of 5.4% during the forecast period (2016–2021).
Increasing incidence of cardiovascular diseases, technological advancements, and advantages of echocardiography over invasive cardiac diagnostic procedures are the major drivers for the cardiovascular ultrasound system market. However, insufficient reimbursement scenario and economic impact of adopting new technologies are restraining the growth of the market.
Download PDF Brochure@
On the basis of technology, the cardiovascular ultrasound system market is segmented into 2D, 3D & 4D, and Doppler imaging. The 2D technology is estimated to account for the largest share of the market in 2016, whereas the 3D & 4D technology segment is estimated to grow at the highest CAGR during the forecast period.
Key questions addressed by the report:
# Who are the major market players in the cardiovascular ultrasound system market?
# What are the regional growth trends and the largest revenue-generating regions for cardiovascular ultrasound system market?
# What are the major drivers and challenges in the cardiovascular ultrasound system market?
# What are the major product segments in the cardiovascular ultrasound system market?
# What are the major end users for cardiovascular ultrasound system?
On the basis of end user, the cardiovascular ultrasound system market is categorized into hospitals, cardiology centers, ambulatory, home care, and other end users (research institutes, medical device and pharmaceutical companies). The hospitals segment is expected to account for the largest share of the market in 2016. The home care & ambulatory segment is estimated to register the highest CAGR during the forecast period due to increase in the usage of echocardiographs at the patient’s house itself.
# Cardiovascular ultrasound system manufacturers
# Cardiovascular ultrasound system distributors and wholesalers
# Pharmaceutical companies
# Various research and consulting firms
# Research institutes
# Contract manufacturing organizations (CMOs)
# Original equipment manufacturers (OEMs)
Request Sample Pages@
Key players in the cardiovascular ultrasound system market include GE Healthcare (U.S.), Philips healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), and Toshiba Medical Systems Corporation (Japan).